These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11595)

  • 1. Activation of latent viruses following bone marrow transplantation.
    Rinaldo CR; Hirsch MS; Black PH
    Transplant Proc; 1976 Dec; 8(4):669-72. PubMed ID: 11595
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of murine cytomegalovirus on cell-mediated immunity.
    Howard RJ; Balfour HH; Seidel MV; Simmons RL; Najarian JS
    Transplant Proc; 1977 Mar; 9(1):355-8. PubMed ID: 17196
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus infection in transplant patients.
    Betts RF
    Prog Med Virol; 1982; 28():44-64. PubMed ID: 6283602
    [No Abstract]   [Full Text] [Related]  

  • 4. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 5. Of mice and men in bone marrow transplantation.
    Mathé G; Schwarzenberg L; Halle-Pannenko O; Abuaf N; Pouillart P
    Transplant Proc; 1977 Mar; 9(1):155-68. PubMed ID: 17189
    [No Abstract]   [Full Text] [Related]  

  • 6. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K; Démant P; Festenstein H; Holmes J; Huber B; Rychiková M
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble H-2 antigens: effect on graft-versus-host reaction and factors influencing its effect on host-versus-skin-graft reaction.
    Halle-Pannenko O; Martyre MC; Mathé G
    Transplant Proc; 1972 Dec; 4(4):517-21. PubMed ID: 4405145
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 10. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors.
    Lerner KG; Kao GF; Storb R; Buckner CD; Clift RA; Thomas ED
    Transplant Proc; 1974 Dec; 6(4):367-71. PubMed ID: 4155153
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
    Trier L; Rubin B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
    [No Abstract]   [Full Text] [Related]  

  • 12. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice.
    Li A; Zhang Q; Jiang J; Yuan G; Feng Y; Hao J; Li C; Gao X; Wang G; Xie S
    Gene Ther; 2006 Aug; 13(15):1178-87. PubMed ID: 16598299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone-marrow transplantation in France, 1958-1973.
    Mathé G; Schwarzenberg L
    Transplant Proc; 1974 Dec; 6(4):335-43. PubMed ID: 4155150
    [No Abstract]   [Full Text] [Related]  

  • 14. Opportunistic infection and interstitial pneumonia following marrow transplantation for aplastic anemia and hematologic malignancy.
    Neiman PE; Thomas ED; Reeves WC; Ray CG; Sale G; Lerner KG; Buckner CD; Clift RA; Storb R; Weiden PL; Fefer A
    Transplant Proc; 1976 Dec; 8(4):663-7. PubMed ID: 186916
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
    de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
    Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
    Wood ML; Gozzo JJ; Monaco AP
    Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of restoring lethally irradiated mice with anti-Thy 1.2-treated bone marrow: graft-vs-host, host-vs-graft, and mitogen reactivity.
    Norin AJ; Emeson EE
    J Immunol; 1978 Mar; 120(3):754-8. PubMed ID: 24664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation incompatibility modified by F 1 graft inocula.
    Chee CA; Ilbery PL; Motta R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow transplantation. Influence of T lymphocytes on the process of differentiation and proliferation of bone marrow cells.
    Vitale B; Burek V; Plavljanić D
    Transplant Proc; 1977 Mar; 9(1):269-72. PubMed ID: 17193
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplantation of autoimmune potential. II. Glomerulonephritis in lethally irradiated DBA/2 recipients of NZB bone marrow cells.
    Morton JI; Siegel BV; Moore RD
    Transplantation; 1975 Jun; 19(6):464-9. PubMed ID: 237350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.